You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》中國實驗室服務商艾迪康再提交上市申請
阿思達克 03-06 09:41
中國三大獨立醫學實驗室(ICL)服務提供商艾迪康再向聯交所提交上市申請,聯席保薦人為摩根士丹利與富瑞。 初步招股文件顯示,艾迪康目前於中國擁有32個自營實驗室,組成集成網絡為醫院和體檢中心提供檢驗服務,截至去年底止檢測量增長至近1.65億次。 艾迪康去年全年收入達48.6億元人民幣,按年增長43.8%,純利則按年升逾115%至6.8億元人民幣。 公司計劃將集資所得,用於加強普檢及特檢能力、通過開設新實驗室等方式拓展網絡、業務開發,以及升級及擴大現有實驗室等。(gc/k) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account